ACAD

ACADIA Pharmaceuticals Inc. News Headlines

$26.64
*  
0.93
3.37%
Get ACAD Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading ACAD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Jim Cramer's Top Stock Picks: TWTR TASR ACAD ISIS RH
9/12/2014 6:00:00 AM - TheStreet

Cramer's Mad Money - 2 Biotech Takeover Targets (9/11/14)
9/12/2014 5:47:00 AM - Seeking Alpha

Why ACADIA Pharmaceuticals (ACAD) Stock Is Spiking Today
9/2/2014 2:38:00 PM - TheStreet

ACADIA: FDA Grants Breakthrough Therapy Status To NUPLAZID
9/2/2014 9:21:00 AM - RTT News

ACADIA: FDA Provisionally Accepts Trade Name, NUPLAZID, For Pimavanserin
8/28/2014 9:10:00 AM - RTT News

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2014 Update
8/23/2014 10:34:00 AM - Seeking Alpha

Edelman's Perceptive Advisors Buying Amicus Therapeutics Ahead Of Phase III Data Release
7/23/2014 9:01:00 AM - Seeking Alpha

ACADIA Pharma Appoints Stephen Davis As CFO - Quick Facts
7/15/2014 9:17:00 AM - RTT News

ACAD Makes Bullish Cross Above Critical Moving Average
7/1/2014 12:08:01 PM - BNK Invest

Friday's ETF Movers: FNX, XBI
6/27/2014 2:16:35 PM - BNK Invest

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 11:41:00 AM - Seeking Alpha

ImmunoCellular Plans To Move ICT-107 Forward Into Phase III Trials Based On New Sub-Group Analysis Presented At ASCO
6/2/2014 10:41:45 AM - SeekingAlpha

Acadia Remains On Track With Pimavanserin Program
5/7/2014 10:41:00 AM - Seeking Alpha

Backtesting A Value Strategy
4/20/2014 7:38:00 AM - Seeking Alpha

Acadia Pharmaceuticals: 4 Different Insiders Have Sold Shares This Month
4/20/2014 7:00:00 AM - Seeking Alpha

From Lab Bench To Bedside: David Lowe Brings Common Sense To Neuroscience Investing
3/30/2014 7:38:00 AM - Seeking Alpha

3 Biotech Stocks Trading The Wrong Direction In March
3/28/2014 4:58:00 PM - Seeking Alpha

Notable Two Hundred Day Moving Average Cross - ACAD
3/25/2014 4:32:50 PM - BNK Invest

An Update On Acadia Pharmaceuticals
3/1/2014 9:34:00 AM - Seeking Alpha

ACADIA Pharmaceuticals (ACAD) Jumps: Stock Rises 17.3% - Tale of the Tape
2/24/2014 10:18:01 AM - Zacks.com

Friday's ETF Movers: XBI, GDXJ
2/21/2014 3:34:33 PM - BNK Invest

Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming
2/11/2014 8:31:00 AM - Seeking Alpha

Cramer's Lightning Round - Archer Daniels Midland Is Much Ado About Nothing (1/30/14)
1/31/2014 6:22:00 AM - Seeking Alpha

Cramer's Lightning Round - Agilent Is Sensational (1/28/14)
1/29/2014 5:16:00 AM - Seeking Alpha

Is The Healthcare Sector Pulling Back Or Crashing?
1/28/2014 5:40:00 AM - Seeking Alpha